Trial · NCT00979121
Results by group28
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 28
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Hospital Mortality to Day 60. | Rosuvastatin | 28.5 | 95% Confidence Interval 24.0 to 33.0 | percentage of participants | |
| Hospital Mortality to Day 60. | Placebo | 24.9 | 95% Confidence Interval 20.5 to 29.3 | percentage of participants | |
| Ventilator Free Days at Study Day 28 | Rosuvastatin | 15.1 | Standard Deviation 10.8 | days | |
| Ventilator Free Days at Study Day 28 | Placebo | 15.1 | Standard Deviation 11.0 | days | |
| Organ Failure Free Days at Day 14 | Rosuvastatin | Cardiovascular | 8.5 | Standard Deviation 4.8 | days |
| Organ Failure Free Days at Day 14 | Placebo | Cardiovascular | 8.7 | Standard Deviation 4.9 | days |
| Organ Failure Free Days at Day 14 | Rosuvastatin | Coagulation | 10.7 | Standard Deviation 5.1 | days |
| Organ Failure Free Days at Day 14 | Placebo | Coagulation | 11.1 | Standard Deviation 4.8 | days |
| Organ Failure Free Days at Day 14 | Rosuvastatin | Hepatic | 10.8 | Standard Deviation 5.0 | days |
| Organ Failure Free Days at Day 14 | Placebo | Hepatic | 11.8 | Standard Deviation 4.3 | days |
| Organ Failure Free Days at Day 14 | Rosuvastatin | Renal | 10.1 | Standard Deviation 5.3 | days |
| Organ Failure Free Days at Day 14 | Placebo | Renal | 11.0 | Standard Deviation 4.7 | days |
| ICU Free Days to Day 28 | Rosuvastatin | 14.3 | Standard Deviation 10.1 | days | |
| ICU Free Days to Day 28 | Placebo | 14.4 | Standard Deviation 10.3 | days | |
| Other Secondary Out-comes | Rosuvastatin | Arrhythmias | 9.0 | 95% Confidence Interval 6.1 to 11.9 | percentage of participants |
| Other Secondary Out-comes | Placebo | Arrhythmias | 8.4 | 95% Confidence Interval 5.5 to 11.3 | percentage of participants |
| Other Secondary Out-comes | Rosuvastatin | Bowel Ischemia | 1.4 | 95% Confidence Interval 0.2 to 2.6 | percentage of participants |
| Other Secondary Out-comes | Placebo | Bowel Ischemia | 1.9 | 95% Confidence Interval 0.5 to 3.3 | percentage of participants |
| Other Secondary Out-comes | Rosuvastatin | Myocardial Infarction | 0.5 | 95% Confidence Interval -0.3 to 1.3 | percentage of participants |
| Other Secondary Out-comes | Placebo | Myocardial Infarction | 0.6 | 95% Confidence Interval -0.2 to 1.4 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00979121/results